Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Hubei Kelaiwei Biological Pharmaceutical Co., Ltd., established on 2019-01-09, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical product production(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd., established on 1993-12-31, Business scope includes pharmaceuticals,Medical device production,Sales;food,Cosmetic sales;Business Consulting;And provide after-sales service and related technical consultation,account Serive,Business Management Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Cypress Bioscience is a medical service provider that facilitates individualized patient care. The service provides its patients with therapeutic and personalized medical services in a variety of needs such as isolated areas of pain, rheumatology, and physical medicine and rehabilitation. It also addresses challenging disorders such as fibromyalgia and rheumatoid arthritis. Furthermore, the organization engages in the development of drugs such as Savella, a milnacipran HCI for the treatment of fibromyalgia, as well as Prosorba, a medical device for rheumatoid arthritis. Cypress Bioscience was founded in 1981 and is based in San Diego, California.

Nanchang Hongyi Technology Co., Ltd., established on 1998-01-04, Business scope includes pharmaceutical,Health products,Technology development in food chemical industry,technology transfer,technical consulting,Technical Services(The operating permit) **

Hainan General Sanyang Pharmaceutical Co. Ltd. is a company headquartered in Haikou, China and ultimately controlled by the Government of China. The firm manufactures and distributes pharmaceuticals.

Zhejiang Puli Pharmaceutical Co., Ltd., established on 2003-08-13, Business scope includes licensed projects:Drug Wholesale;Drug retail;pharmaceutical production;Production of Class II Medical Devices;food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Pharmaceutical special equipment sales;Machinery sales;Metal Material Sales;food sales(Only sell prepackaged food);Chemical product sales(No licensed chemical products);Sales of electronic components and electromechanical components;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Hainan Poly Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The firm is specialized in injections and oral solid formulations. Its products include injection, oral solid dosage, dry suspension and active pharmaceutical ingredient (API). The company was founded by Min Hua Fan on July 14, 1992 and is headquartered in Haikou, China.

Hainan General & Kangli Pharmaceutical Co., Ltd. is a company headquartered in China ultimately controlled by the Government of China. The firm manufactures and wholesales pharmaceutical products.

Shandong Fangming Pharmaceutical Stock Co. Ltd. is a private company headquartered in Shandong, China, with operations in China. The firm manufactures and supplies pharmaceutical products.

Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd., established on 2016-09-01, The scope of business includes the production of hazardous chemicals(Engage in business according to the approved items and time limit of the license);research and development,Production,selling medicines;Research,Develop fine chemical products,specialty chemicals;Production,Sales of chemical products;medicine,Chemical Products(The above business scope does not include hazardous chemicals other than those approved by the license)technology transfer;Import and export.(Items subject to approval according to law in the above scope,Business activities can only be carried out after approval by relevant departments)**

Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. is a company headquartered in Beijing, China, focused on commercial physical and biological research.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Shanghai Huali Biomedical Co., Ltd., established on 2005-01-27, Business scope includes biological,medicine,new material,Technology development in the field of fine chemical engineering,Technical Services,technical consulting,Technology transfer and high-tech product development,Chemical raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),chemical reagent,Instrumentation,Sales of general machinery,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., established on 1996-04-24, Business scope includes licensed projects:Disinfectant production(Free of Hazardous Chemicals);pharmaceutical production;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:Medical Technology Development,Technical Services,technical consulting,technology transfer;Import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]Production of small volume injections,large volume injection,powder injection(Contains cephalosporins),tablet(Contains anti-tumor),hard capsule(Contains anti-tumor),Granules,Powder,inhalation solution,powder injection(Penicillins),small volume injection(extract)(Engage in business according to the items and time limit approved by the license).**.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Jiangsu Hanstone Pharmaceutical Co., Ltd., established on 2003-05-23, Business scope includes pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)